RxDoctor Payments Data

Joseph Cicenia, MD

Pulmonary Disease · Cleveland, OHNPI 1699821009

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (34.2%), speaking fees and education — rather than concentrated in one kind of arrangement. Noah Medical Corporation accounts for 72.9% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $139,484, more than ten times the $8,155 reported in 2019. Among pulmonary disease clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$349,812in general payments, 2019–2025

Across 390 payments — averaging $896.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Noah Medical Corporation$255K
  • Johnson & Johnson$32K
  • Body Vision Medical Inc.$28K
  • Boston Scientific$15K
  • Ethicon Endo-surgery Inc.$8K
  • Intuitive Surgical$4K
  • plus $9K from 17 others

What the payments were for

  • Consulting fees$119,52434%
  • Speaking & faculty fees$99,33128%
  • Travel & lodging$37,92911%
  • Food & beverage$21,9036%
  • Education$71,12520%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Noah Medical Corporation170$254,963
Johnson & Johnson(2 entities)71$31,628
Body Vision Medical Inc.21$27,653
Boston Scientific57$14,747
Ethicon Endo-surgery Inc.4$7,646
Intuitive Surgical11$3,959
AstraZeneca1$3,890
Galvanize Therapeutics, Inc18$1,595
Covidien LP9$979
Pulmonx Corporation4$648
Ambu A/s1$500
Getinge USA Sales, LLC6$293
Steris Corporation1$233
Philips North America LLC3$189
Auris Health, Inc.2$187
Broncus Medical1$177
Ambu Inc.2$130
Olympus America Inc.1$103
4dmedical USA Inc3$96
Siemens Medical Solutions USA, Inc.1$84
Acclarent, Inc1$81
Bard Peripheral Vascular, Inc.1$20
Rocket Medical LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$349,812 in reported general payments places this provider in the 95th percentile of 571 pulmonary disease providers in Ohio.

See all pulmonary disease providers in Ohio

Medicare billing

Part B allowed, 2024
$47,720
Medicare patients
186
Services billed
464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,480
Spiriva RespimatTiotropium Bromide14$7,258
Albuterol Sulfate HfaAlbuterol Sulfate21$564
Prednisone28$61

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →